期刊文献+

Toll样受体在鼻咽癌中的研究进展 被引量:1

Research progress of Toll-like receptors in nasopharyngeal carcinoma
下载PDF
导出
摘要 鼻咽癌是我国常见的头颈部恶性肿瘤之一。Toll样受体(Toll-like receptors,TLRs)在免疫细胞中激活,不仅可以介导免疫反应,发挥抗肿瘤的作用,还可以产生免疫抑制因子促进肿瘤的免疫逃逸。Toll样受体在肿瘤细胞中激活不仅可以促进肿瘤细胞的增殖侵袭、转移能力和多药耐药抵抗,还能使肿瘤细胞逃避免疫监视。本文就Toll样受体在鼻咽癌中的作用机制及研究进展进行综述。 Nasopharyngeal carcinoma is one of the most common cancers of the head and neck in China.Toll like receptors(TLRs)are activated in immune cells,which can not only mediate immune response and play an anti-tumor role,but also produce immunosuppressive factors to promote tumor immune escape.In addition to promoting the proliferation,invasion and metastasis of tumor cells and multidrug resistance,Toll like receptors activation in tumor cells also helps tumor cells to evade immune surveillance.In this review,we reviewed the research progress of TLRs in nasopharyngeal carcinoma.
作者 王予 曹现宝 阚晓丽 WANG Yu;CAO Xianbao;KAN Xiaoli(Department of Otolaryngology,The First People's Hospital of Yunnan Province,Kunming Yunnan 650000,China;Kunming Medical University,Kunming Yunnan 650000,China;Department of Infection,The 920th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army,Kunming Yunnan 650000,China)
出处 《转化医学杂志》 2021年第3期187-190,共4页 Translational Medicine Journal
关键词 TOLL样受体 鼻咽癌 作用机制 Toll-like receptors(TLRs) Nasopharyngeal carcinoma Mechanism of Action
  • 相关文献

参考文献6

二级参考文献41

  • 1Xuan Zhou Chunsheng Kang Peiyu Pu.MicroRNA and Brain Tumors[J].Chinese Journal of Clinical Oncology,2007,4(5):355-359. 被引量:4
  • 2柳晓泉,陈渊成,郝琨,曹彦光,余丹.药动学-药效学结合模型的研究进展及在新药研发中的应用[J].中国药科大学学报,2007,38(6):481-488. 被引量:23
  • 3Zhang SY, Herman M, Ciancanelli MJ, Perez de Diego R, Sancho-Shimizu V,Abel L, et al. TLR3 immunity to infection in mice and humans. Curr OpinImmunol. 2013;25:19–33.
  • 4Frazao JB, Errante PR, Condino-Neto A. Toll-like receptors’ pathwaydisturbances are associated with increased susceptibility to infections inhumans. Arch Immunol Ther Exp (Warsz). 2013;61:427–43.
  • 5Netea MG, Wijmenga C, O’Neill LA. Genetic variation in Toll-like receptorsand disease susceptibility. Nat Immunol. 2012;13:535–42.
  • 6He JF, Jia WH, Fan Q, Zhou XX, Qin HD, Shugart YY, et al. Geneticpolymorphisms of TLR3 are associated with nasopharyngeal carcinoma riskin Cantonese population. BMC Cancer. 2007;7:194.
  • 7Singh V, Srivastava N, Kapoor R, Mittal RD. Single-nucleotide polymorphismsin genes encoding Toll-like receptor-2, -3, -4, and -9 in a case-control studywith bladder cancer susceptibility in a North Indian population. Arch MedRes. 2013;44:54–61.
  • 8Mandal RK, George GP, Mittal RD. Association of Toll-like receptor (TLR) 2, 3and 9 genes polymorphism with prostate cancer risk in North Indianpopulation. Mol Biol Rep. 2012;39:7263–9.
  • 9Pandey S, Mittal B, Srivastava M, Singh S, Srivastava K, Lal P, et al. Evaluationof Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms incervical cancer susceptibility. Mol Biol Rep. 2011;38:4715–21.
  • 10Etokebe GE, Knezevic J, Petricevic B, Pavelic J, Vrbanec D, Dembic Z.Single-nucleotide polymorphisms in genes encoding toll-like receptor-2,-3, -4, and -9 in case-control study with breast cancer. Genet Test MolBiomarkers. 2009;13:729–34.

共引文献98

同被引文献6

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部